The Europe biosimilar market reached a value of USD 10.13 Billion in 2024, driven by the extended application of biosimilars in managing various chronic conditions across the region. The market is further expected to grow at a CAGR of 12.80% between 2025-2034 to reach a value of almost USD 33.78 Billion by 2034.
Get a Free Sample Report with a Table of...
Greek
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
melayu